Search - tctmd.com

Displaying 521 - 540 of 901

Sort: Relevancy | Date

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Short DAPT IDE Trials

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Ajay J. Kirtane

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan

October 30, 2017

Presentation TCT 2017

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Presenter: Gregg W. Stone, Bram D. Zuckerman, Alan G. Fraser

October 30, 2017

Presentation TCT 2017

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

Presenter: Gregg W. Stone, Bram D. Zuckerman, William H. Maisel

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman, Richard E. Kuntz

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 30, 2017

Presentation ISCTR 2017

Valve Disease/Transcatheter Aortic Valve Replacement: Regulatory Point of View

Presenter: Jaime Raben

October 29, 2017

News Daily News

Merck Calls Quits on CETP Inhibitor Anacetrapib

Michael O'Riordan

October 12, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

Yael L. Maxwell

October 02, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

Todd Neale

September 19, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

Advertisement

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

FDA Perspectives on Short DAPT IDE Trials

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

The Landscape of CV Device Innovation for Children: Regulatory View

The Landscape of CV Device Innovation for Children: Regulatory View

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Valve Disease/Transcatheter Aortic Valve Replacement: Regulatory Point of View

Merck Calls Quits on CETP Inhibitor Anacetrapib

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Generic ARBs Linked to Increased Adverse Events

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

New Performance and Quality Metrics for STEMI and NSTEMI Care

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content